# Instituto Nacional de Pediatria

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/instituto-nacional-de-pediatria/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 50 |
| Citations | 230,425 |
| City | Mexico City |
| Country | MX |
| Description | Instituto Nacional de Pediatria is a research organisation in Mexico City, MX. OpenAlex records 7,235 works and 230,425 citations for it. 3,190 researchers list it as their most recent affiliation. |
| Homepage | http://www.pediatria.gob.mx/english_version.html |
| OpenAlex ID | https://openalex.org/I4210146908 |
| Researchers | 3,190 |
| ROR ID | https://ror.org/05adj5455 |
| Type | facility |
| Works | 7,235 |

## University papers

- [Frailty Consensus: A Call to Action](https://scholariq.org/papers/frailty-consensus-a-call-to-action/)
- [The burden of disease in older people and implications for health policy and practice](https://scholariq.org/papers/the-burden-of-disease-in-older-people-and-implications-for-health-policy-and/)
- [International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines](https://scholariq.org/papers/international-exercise-recommendations-in-older-adults-icfsr-expert-consensus/)
- [Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management](https://scholariq.org/papers/physical-frailty-icfsr-international-clinical-practice-guidelines-for/)
- [The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors](https://scholariq.org/papers/the-safety-tolerability-and-efficacy-of-once-daily-memantine-28-mg-a/)

## University top topics

Showing 8 of 24.

- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Nutrition and Health in Aging](https://scholariq.org/topics/nutrition-and-health-in-aging/)
- [Metabolism and Genetic Disorders](https://scholariq.org/topics/metabolism-and-genetic-disorders/)
- [Aging, Health, and Disability](https://scholariq.org/topics/aging-health-and-disability/)
- [Frailty in Older Adults](https://scholariq.org/topics/frailty-in-older-adults/)
- [Health and Lifestyle Studies](https://scholariq.org/topics/health-and-lifestyle-studies/)
- [Child and Adolescent Health](https://scholariq.org/topics/child-and-adolescent-health/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.